跳至主要内容
临床试验/CTRI/2022/05/042635
CTRI/2022/05/042635招募中1 期

Evaluation of the combined effect of Mahatriphladi Ghrita Nasya, Tarpana, Pana and Rakta-mokshana in Adhimantha (POAG)

Patanjali Bhartiya Ayurvigyan evam Anusandhana Sansthana Haridwar0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Age 30 To 70 years
  • 2. Patients of either sex.
  • 3. Patients of POAG having IOP < 21mmHg and IOP > 21 mmHg.
  • 4. Visual acuity more than 6/60 and clear media.
  • 5. Patients of POAG

排除标准

  • 1.Age below 30 years and above 70 years.
  • 2. Visual acuity less than 6/60
  • 3. Secondary and developmental Glaucoma including exfoliative glaucoma, pigmentary glaucoma,trauma-induced, inflammatory glaucoma, family history of glaucoma
  • 4. Evidence of any anterior segment pathology like conjunctivitis, keratitis, or acute uveitis.
  • 5. History of opaque ocular media (as in cataracts, corneal opacities, vitreous opacities).
  • 6. Pregnant women
  • 7.Any malignancy, uncontrolled diabetes, uncontrolled hypertension.
  • 8.People who are already registered under some other ongoing medical research
  • 9. Contraindicated for Nasya.
  • 10.Contraindicated for Tarpana.
  • Contraindicated for Rakta-mokshana (jalaukavcharan)

研究者

发起方
Patanjali Bhartiya Ayurvigyan evam Anusandhana Sansthana Haridwar

相似试验